Meyka Pro banner
Paragon 28, Inc.

Paragon 28, Inc. (FNA) Stock Overview

Explore Paragon 28, Inc.’s financial performance, market position, analyst ratings, and future outlook.

FNANYSE
HealthcareMedical - Devices
$13.09
$0.00(0.00%)
U.S. Market opens in 3h 5m

Paragon 28, Inc. (FNA)

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E Ratio-19.83
EPS (TTM)$-0.66
ROE-0.35%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$1.36

FNA Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Paragon 28, Inc. (NYSE: FNA) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Paragon 28, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of FNA on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $1.36 for the NYSE listing.

Key metrics behind Paragon 28, Inc.'s NYSE-traded stock include a P/E ratio of -19.83 and a market capitalization of 1.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of FNA on the NYSE.

Price Performance (NYSE: FNA)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
0.15%
6-Month Change
30.77%
Year-to-Date (YTD) Change
22.11%
1-Year Change
70.89%
3-Year Change
-16.57%
5-Year Change
-30.04%
All-Time (Max) Change
-30.04%

Contact Information

730 399 3400
14445 Grasslands Drive, Englewood, CO, 80112

Company Facts

5,250 Employees
IPO DateOct 15, 2021
CountryUS

Frequently Asked Questions